1μg (R: reducing condition, N:non-reducing condition).
Product Details
Product Details
Product Specification
| Species | Cynomolgus |
| Synonyms | CD8, Leu2, MAL, p32 |
| Accession | XP_065382910.1 |
| Amino Acid Sequence | Ser22-Asp182 with His&Avi Tag at the C-Terminus |
| Expression System | HEK293 |
| Molecular Weight | 25-35kDa (Reducing) |
| Purity | >95% by SDS-PAGE |
| Conjugation | Biotin |
| Tag | Avi Tag, His Tag |
| Physical Appearance | Lyophilized powder |
| Storage Buffer | PBS, PH7.4, 5% trehalose |
| Reconstitution | Reconstitute at 0.1-1 mg/ml according to the size in ultrapure water after rapid centrifugation. |
| Stability & Storage | · 12 months from date of receipt, lyophilized powder stored at -20 to -80℃. |
| Reference | 1.Gao GF, Tormo J, Gerth UC, Wyer JR, McMichael AJ, Stuart DI, Bell JI, Jones EY, Jakobsen BK. Crystal structure of the complex between human CD8alpha(alpha) and HLA-A2. Nature. 1997 Jun 5;387(6633):630-4. |
Background
Cynomolgus macaque (Macaca fascicularis) CD8A shares high sequence homology with human CD8α (approximately 95%), and its CD8+ T cells are highly conserved with humans in terms of immunophenotype, signal transduction, and function. CD8α forms an Ig-like domain dimer that binds to the α3 domain of MHC class I molecules through CDR-like loops, thereby enhancing the recognition affinity of TCR for antigens. Cynomolgus CD8+ T cells serve as a critical model for evaluating HIV/SIV vaccines, immune checkpoint inhibitors (such as anti-PD-1/PD-L1), and bispecific antibodies (such as B7-H4×CD3). The cynomolgus macaque model is utilized to predict the toxicity (such as cytokine release syndrome) and efficacy of immunotherapeutic drugs, wherein CD8+ T cell depletion experiments represent the gold standard for validating vaccine protective mechanisms and the effectiveness of immunotherapy targets.
Picture
Picture
SDS-PAGE
ELISA

Immobilized Biotinylated CD8 alpha/CD8A His&Avi Tag Protein, Cynomolgus(Cat. No. UA016044) at 0.5μg/mL (100μL/well) on Streptavidin precoated (0.5μg/well) plate, can bind CD8a Monoclonal Antibody (OKT8) with EC50 of 0.68-0.90 ng/mL.
Immobilized Biotinylated CD8 alpha/CD8A His&Avi Tag Protein, Cynomolgus (Cat. No. UA016044) at 0.5 μg/mL (100 μL/well) on Streptavidin precoated (0.5ug/well) plate, can bind CD8α Mouse mAb (SDT-1036-34) (Cat. No. S0B2307) with EC50 of 1.13-1.60 ng/mL.
